Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile

被引:21
|
作者
Odenholt, Inga [1 ]
Walder, Mats
Wullt, Marlene
机构
[1] Lund Univ, Dept Clin Sci, Infect Dis Res Unit, SE-20502 Malmo, Sweden
[2] Lund Univ, Dept Expt Sci, Malmo, Sweden
关键词
pharmacodynamic effect; postantibiotic effect; postantibiotic sub-MIC effect; Clostridium difficile; vancomycin; metronidazole; fusidic acid; STAPHYLOCOCCUS-AUREUS; DIARRHEA; SUSCEPTIBILITY; INFECTION; COLITIS; INVIVO; CIPROFLOXACIN; ROXITHROMYCIN; OUTBREAK; INVITRO;
D O I
10.1159/000104471
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Pharmacodynamic studies of antibiotics have attracted great interest in recent years. However, studies on the pharmacodynamics of different antibiotics against Clostridium difficile are scarce. Methods: The postantibiotic effects (PAE) and the postantibiotic sub-minimum inhibitory concentration (MIC) effects (PA SME) of vancomycin, metronidazole and fusidic acid were investigated by viable counts against three different strains of C. difficile. The killing rate and extent of the three antibiotics against the same strains were also studied by adding 2, 4, 8, 16 and 32 ! MIC of the three antibiotics, respectively. Results: Metronidazole exerted a very rapid bactericidal effect at concentrations of 8 ! MIC and above against all three strains investigated. Vancomycin gave overall less kill in comparison to metronidazole and was bacteriostatic against two of the three strains. Fusidic acid exerted a concentration-dependent killing against two of the strains. Vancomycin exerted short PAEs and PA SMEs against all three strains. Significantly longer PAEs and PA SMEs were noted for fusidic acid. Metronidazole gave similar short PAEs like vancomycin but longer PA SMEs were noted against two of the investigated strains. Conclusion: Metronidazole exerted the most prominent bactericidal effect greater than fusidic acid and greater than vancomycin. Fusidic acid gave overall the longest PAEs and PA SMEs greater than metronidazole and greater than vancomycin. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 50 条
  • [21] Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey, C. F.
    Eckmann, L.
    Fuhrmann, V.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1239 - 1250
  • [22] Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination
    Erikstrup, Lise Tornvig
    Aarup, Mie
    Hagemann-Madsen, Rikke
    Dagnaes-Hansen, Frederik
    Kristensen, Brian
    Olsen, Katharina Elisabeth Pribil
    Fuursted, Kurt
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [23] A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE
    Leinwand, B.
    VALUE IN HEALTH, 2017, 20 (09) : A632 - A633
  • [24] NON-CLOSTRIDIUM DIFFICILE PSEUDOMEMBRANOUS COLITIS RESPONDING TO BOTH VANCOMYCIN AND METRONIDAZOLE
    PHILLIPS, RKS
    GLAZER, G
    BORRIELLO, SP
    BRITISH MEDICAL JOURNAL, 1981, 283 (6295): : 823 - 823
  • [25] A survey of metronidazole and vancomycin resistance in strains of Clostridium difficile isolated in Warsaw, Poland
    Pituch, H
    Obuch-Woszczatynski, P
    Wultanska, D
    Meisel-Mikolajczyk, F
    Luczak, M
    ANAEROBE, 2005, 11 (04) : 197 - 199
  • [26] Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile
    Noren, T.
    Akerlund, T.
    Wullt, M.
    Burman, L. G.
    Unemo, M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) : 1840 - 1843
  • [27] Metronidazole resistance in Clostridium difficile
    Johnson, S
    Sanchez, JL
    Gerding, DN
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) : 625 - 626
  • [28] Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
    Stevens, Vanessa W.
    Nelson, Richard E.
    Schwab-Daugherty, Elyse M.
    Khader, Karim
    Jones, Makoto M.
    Brown, Kevin A.
    Greene, Tom
    Croft, Lindsay D.
    Neuhauser, Melinda
    Glassman, Peter
    Goetz, Matthew Bidwell
    Samore, Matthew H.
    Rubin, Michael A.
    JAMA INTERNAL MEDICINE, 2017, 177 (04) : 546 - 553
  • [29] DIARRHEA CAUSED BY CLOSTRIDIUM-DIFFICILE - RESPONSE-TIME FOR TREATMENT WITH METRONIDAZOLE AND VANCOMYCIN
    WILCOX, MH
    HOWE, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (04) : 673 - 679
  • [30] Susceptibility of Clostridium difficile Isolated from Healthy Captive Asian Elephants to Metronidazole and Vancomycin
    Sthitmatee, Nattawooti
    Warinrak, Thanya
    Wongkalasin, Waroot
    THAI JOURNAL OF VETERINARY MEDICINE, 2013, 43 (02): : 313 - 316